Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference63 articles.
1. Kansara M, Teng MW, Smyth MJ, et al. Translational biology of osteosarcoma. Nat Rev Cancer. 2014;14(11):722–35.
2. Gorlick R, Anderson P, Andrulis I, et al. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin Cancer Res. 2003;9:5442–53.
3. Lu C, Ding L, Mardis EER, Wilson RKR, et al. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep. 2014;7:104–12.
4. Heymann D. Metastatic osteosarcoma challenged by regorafenib. Lancet Oncol. 2019;20:12–3.
5. Bielack SS, Smeland S, Xhelan JS, et al. Methotexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa 2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP. First results of the EURAMOS-1 gooe response randomized controlled yitla. J Clin Oncol. 2015;33:2279–87.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献